Therefore, our research group intends to apply PSMA- PET to elderly patients with PIRADS 5 lesions, to explore whether patients with PSMA- PET showing the possibility of prostate cancer can be directly treated with antitumor therapy without experiencing the pain and risk of operation. The gene discussed is FOLH1; the disease is prostate carcinoma.